Complement 3 Glomerulopathy (C3G)

DBCOND0138498Immune System DiseasesUrogenital Diseases

Complement 3 Glomerulopathy (C3G) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
C3G · C3 Glomerulopathy · C3 Glomerulopathy (C3G) · Complement 3 Glomerulopathy · Complement 3 Glomerulonephritis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000756166SNOMED CT722758004MedDRA10077827UMLSC4087273

What you can answer from here — as of October 24, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
25Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Complement 3 Glomerulopathy (C3G) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In